The FDA has approved the inclusion of new evidence to the prescribing label for secukinumab for the treatment of psoriatic arthritis. READ MORE
Collaborating Associations
Business Insider Series
This article describes the current federal policy debate regarding compounding and offers suggestions on how physicians can make their voices heard.
Aesthetics Corner
Antioxidants plus devices yield optimal aesthetic outcomes.
Supplements
